官方服务：
资源简介：
Inhibition of EZH2 in THP-1 cells
应用场景：
创建时间：
2015-08-04
相关数据集
Common differentiating agents facilitate transcriptional reprogramming by bromodomain inhibition
Dimethyl sulfoxide (DMSO) and hexamethylene bisacetamide (HMBA) are biologically active molecules that have shown clinical efficacy in cancer and inflammation, though their therapeutic application has
NIAID Data Ecosystem70
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia. A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia
This SuperSeries is composed of the SubSeries listed below. Overall design: Refer to individual Series
NIAID Data Ecosystem40
Immunomodulatory effect of 5-azacytidine (5-azaC): potential role in the transplantation setting.
Cytokine genes are targets of multiple epigenetic mechanisms in T lymphocytes. 5-azacytidine (5-azaC) is a nucleoside-based DNA methyltransferases (DNMT) inhibitor which induces demethylation and gene
NIAID Data Ecosystem20
The phosphorylated prodrug FTY720 is a histone deacetylase Q15 inhibitor that reactivates ERα expression and enhances hormonal therapy for breast cancer
Nuclear FTY720-P is a potent inhibitor of class I histone deacetylases (HDACs) that enhances histone acetylations and regulates expression of a restricted set of genes independently of its known effec
NIAID Data Ecosystem50
Additional file 12 of Therapeutical interference with the epigenetic landscape of germ cell tumors: a comparative drug study and new mechanistical insights
Additional file 12: Table S2. A Studied cell lines including appropriate culture conditions. B Sequences of used oligonucleotides. C Epi-drug solvents and suppliers. D Used antibodies.
Figshare2022-01-08 更新30
